These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 21884674)
1. New observations on the "early repolarization syndrome". Márquez MF Heart Rhythm; 2012 Jan; 9(1):84-5. PubMed ID: 21884674 [No Abstract] [Full Text] [Related]
2. Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome. Kawata H; Noda T; Yamada Y; Okamura H; Satomi K; Aiba T; Takaki H; Aihara N; Isobe M; Kamakura S; Shimizu W Heart Rhythm; 2012 Jan; 9(1):77-83. PubMed ID: 21855521 [TBL] [Abstract][Full Text] [Related]
3. Re: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. Madias JE J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E32; author reply E33. PubMed ID: 18298519 [No Abstract] [Full Text] [Related]
4. Quinidine: a valuable medication joins the list of 'endangered species'. Viskin S; Antzelevitch C; Márquez MF; Belhassen B Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793 [No Abstract] [Full Text] [Related]
5. One small step. Link M; Kowey P Pacing Clin Electrophysiol; 2009 Mar; 32(3):291-3. PubMed ID: 19272056 [No Abstract] [Full Text] [Related]
6. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'. Bozic B; Uzelac TV; Kezic A; Bajcetic M Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701 [TBL] [Abstract][Full Text] [Related]
7. Effect of flecainide on suppression of ventricular fibrillation in a patient with early repolarization syndrome. Ahn J; Roh SY; Lee DI; Shim J; Choi JI; Kim YH Heart Rhythm; 2016 Aug; 13(8):1724-8. PubMed ID: 27033341 [No Abstract] [Full Text] [Related]
8. Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome. Chinushi M; Iijima K; Tagawa M; Komura S; Furushima H; Aizawa Y J Electrocardiol; 2009; 42(4):367-73. PubMed ID: 19356768 [TBL] [Abstract][Full Text] [Related]
9. Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome. Poli S; Toniolo M; Maiani M; Zanuttini D; Rebellato L; Vendramin I; Dametto E; Bernardi G; Bassi F; Napolitano C; Livi U; Proclemer A Europace; 2018 Feb; 20(2):234-242. PubMed ID: 28521022 [TBL] [Abstract][Full Text] [Related]
10. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Belhassen B; Glick A; Viskin S Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057 [TBL] [Abstract][Full Text] [Related]
11. Treatment of ventricular fibrillation storm in Brugada syndrome: weathering the storm but staying in hot water? Shvilkin A Heart Rhythm; 2007 Jun; 4(6):701-2. PubMed ID: 17556187 [No Abstract] [Full Text] [Related]
12. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. Tada T; Kusano KF; Nagase S; Banba K; Miura D; Nishii N; Watanabe A; Nakamura K; Morita H; Ohe T J Cardiovasc Electrophysiol; 2008 Jan; 19(1):56-61. PubMed ID: 17916151 [TBL] [Abstract][Full Text] [Related]
13. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome. Sumi S; Maruyama S; Shiga Y; Kodama S; Miyoshi K; Tojou H; Yamanouchi Y; Urata H Pacing Clin Electrophysiol; 2010 Jun; 33(6):e53-6. PubMed ID: 20059716 [TBL] [Abstract][Full Text] [Related]
14. Ventricular arrhythmias in the absence of structural heart disease. Prystowsky EN; Padanilam BJ; Joshi S; Fogel RI J Am Coll Cardiol; 2012 May; 59(20):1733-44. PubMed ID: 22575310 [TBL] [Abstract][Full Text] [Related]
15. Drug challenge with sodium-channel blockade: improving phenotypic characterization of early repolarization. Ilkhanoff L; Knight BP Heart Rhythm; 2012 Feb; 9(2):240-1. PubMed ID: 21964324 [No Abstract] [Full Text] [Related]
16. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Watanabe H; Nogami A; Ohkubo K; Kawata H; Hayashi Y; Ishikawa T; Makiyama T; Nagao S; Yagihara N; Takehara N; Kawamura Y; Sato A; Okamura K; Hosaka Y; Sato M; Fukae S; Chinushi M; Oda H; Okabe M; Kimura A; Maemura K; Watanabe I; Kamakura S; Horie M; Aizawa Y; Shimizu W; Makita N Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):874-81. PubMed ID: 22028457 [TBL] [Abstract][Full Text] [Related]
17. Right coronary cusp as a new window of ablation for pilsicainide-induced ventricular premature contractions in a patient with Brugada syndrome. Yamasaki H; Tada H; Sekiguchi Y; Aonuma K Heart Vessels; 2016 Aug; 31(8):1397-401. PubMed ID: 26510553 [TBL] [Abstract][Full Text] [Related]
18. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs. Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972 [TBL] [Abstract][Full Text] [Related]
19. Quinidine in Brugada Syndrome: Still a Long Way to Go…. Probst V; Gourraud JB Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1309-10. PubMed ID: 26671933 [No Abstract] [Full Text] [Related]